Granisetron Hydrochloride
CAS 107007-99-8 13 FDA-DMF suppliersSmall Molecule
Overview
Granisetron Hydrochloride is a serotonin 5-HT3 receptor antagonist used primarily as an antiemetic to treat nausea and vomiting following chemotherapy. It works by blocking serotonin from binding to 5-HT3 receptors located on vagal nerve terminals and in the chemoreceptor trigger zone.
API suppliers (22)
Suppliers of Granisetron Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Natco PharmaIndia1 active DMF
- WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
- INKE SASpain1 active DMF
- WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
- Wockhardt LimitedIndia1 active DMF
- Natco PharmaIndia1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- SCINOPHARM TAIWAN LTD1 active DMF
- INKE SASpain1 active DMF
- Natco PharmaIndia1 active DMF
- Wockhardt LimitedIndia1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- SCINOPHARM TAIWAN LTD1 active DMF
- INKE SASpain1 active DMF
- Natco PharmaIndia1 active DMF
- Wockhardt LimitedIndia1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- SCINOPHARM TAIWAN LTD1 active DMF
- F2 CHEMICALS LTD
- Sun Pharmaceutical Industries LimitedIndia
- MYLAN LABORATORIES LTD
- HAMARI CHEMICALS LTD
Therapeutic areas
OncologyGastroenterology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.